Concepedia

Libo Chen

LC

Statistics

Publications

13

Citations

404

H-Index

11

Active since

2008

Affiliations

Shanghai Jiao Tong University(Current)

Shanghai Sixth People's Hospital

Shanghai Chest Hospital

Shanghai Tenth People's Hospital

Tongji University

Libo Chen is an author at Shanghai Jiao Tong University specializing in thyroid cancer, medicine, and oncology.

Publications per year

2008–2022

13

Publications

13

IGF2BP2-dependent activation of ERBB2 signaling contributes to acquired resistance to tyrosine kinase inhibitor in differentiation therapy of radioiodine-refractory papillary thyroid cancer

Ri Sa, Rui Liang, Xian Qiu et al. · Cancer Letters · 2021 · 61 citations

, , +17

HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E

Lingxiao Cheng, Yuchen Jin, Min Liu et al. · Oncotarget · 2017 · 55 citations · Full text

, , +14

MAPK Inhibitors Enhance HDAC Inhibitor-Induced Redifferentiation in Papillary Thyroid Cancer Cells Harboring BRAFV600E: An In Vitro Study

Hao Fu, Lingxiao Cheng, Yuchen Jin et al. · Molecular Therapy — Oncolytics · 2019 · 50 citations · Full text

, , +17

Predicting 131I-avidity of metastases from differentiated thyroid cancer using 18F-FDG PET/CT in postoperative patients with elevated thyroglobulin

Min Liu, Lingxiao Cheng, Yuchen Jin et al. · Scientific Reports · 2018 · 39 citations · Full text

, , +17

Clinicopathological Features Predict Outcomes in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Real-World Study

Lin Cheng, Hao Fu, Yuchen Jin et al. · The Oncologist · 2020 · 35 citations · Full text

, , +13

1–5 of 13